Sign inJoin waitlistJoin the waitlist

Imre Noth

Division Chief · University of Virginia Medical Center

Credentials: · · · · ·

History

Division of Pulmonary and Critical Care Medicine · University of Virginia
2018–Present
University of Virginia Medical Center
Present
Division of Pulmonary and Critical Care Medicine · University of Virginia Medical Center
Present

University of Chicago Medical Center
1997–1999
Internal Medicine
University of California (Davis) Medical Center
1992–1995
Georgetown University
University of Arizona
1988–1992
University of Pennsylvania
1984–1988

Research

Acute exacerbations of idiopathic pulmonary fibrosis
Review · American Journal of Respiratory and Critical Care Medicine · 2007 · 877 citations
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
European Respiratory Journal · 2015 · 779 citations
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
The Lancet Respiratory Medicine · 2013 · Co-first of 21 authors · 483 citations

JO
Justin Oldham
88 papers
Mary Strek
68 papers
Ayodeji Adegunsoye
65 papers
Fernando Martinez
63 papers
Toby Maher
39 papers
John Kim
37 papers · 33 as a resident
RV
Rekha Vij
32 papers
Naftali Kaminski
31 papers
Ganesh Raghu
30 papers
Kevin Flaherty
29 papers
Cathryn Lee
23 papers · 17 as a resident
Christine Garcia
23 papers

Grants

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.2M · University of Virginia
2024–2029
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) Trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases Study
National Heart, Lung, and Blood Institute · UH3
PI · $11.6M · Univ of Massachusetts Med Sch Worcester
2020–2027
Architectural Structure and Regulation of TOLLIP in IPF
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.1M · University of Virginia
2016–2022
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) Trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases Study
National Heart, Lung, and Blood Institute · UG3
PI · $976.5K · Weill Medical Coll of Cornell Univ
2019–2021

Clinical trials

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Principal investigator · Recruiting
University of Massachusetts, Worcester
2025–2029
Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
Principal investigator · Completed · Phase 3
Fernando J Martinez
2020–2026
University of Virginia Natural History Study
Principal investigator · Enrolling by invitation
University of Virginia
2018–2035
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Principal investigator · Completed · Phase 3
Duke University
2009–2014